Prof. Yan Niu | Pharmaceutical Chemistry | Research Excellence Award
Peking University | China
Prof. Yan Niu has established a solid and credible scholarly footprint within the global pharmaceutical sciences community, as demonstrated by his citation performance and publication metrics. His research portfolio comprises 46 peer-reviewed scientific documents, published in reputable international journals indexed in major databases such as Scopus and SCI. These publications collectively have attracted 538 citations, reflecting sustained academic attention and continued relevance of his work. Importantly, these citations originate from 447 independent citing documents, indicating that his research has been widely referenced across diverse studies rather than concentrated within a narrow citation network.An h-index of 14 further illustrates the balance between productivity and impact in Prof. Niu’s academic career. This metric signifies that at least fourteen of his publications have each received a minimum of fourteen citations, underscoring consistent influence across multiple research outputs rather than reliance on a small number of highly cited papers. Such a profile is characteristic of researchers whose work contributes foundational knowledge and methodological innovation to their field.The citation impact of Prof. Niu’s publications is closely aligned with the scientific significance of his research areas, particularly targeted protein degradation, amino acid-based hydrophobic tagging strategies, and the discovery and optimization of biologically active small molecules. These topics are at the forefront of modern drug discovery, attracting interdisciplinary interest from medicinal chemists, pharmacologists, and translational researchers. Collectively, his citation metrics not only quantify academic recognition but also reflect the practical and conceptual value of his contributions to advancing innovative therapeutic strategies and expanding the chemical biology toolkit available to pharmaceutical research.
600
450
300
150
0
538
46
14
Featured Publications
Identification of Boc2Lys-Linked Ethacrynic Acid and Its Analogues as Efficient Glutathione S-Transferase Degraders
– ACS Medicinal Chemistry Letters
Nitazoxanide Reduces Inflammation and Bone Erosion in Collagen-Induced Arthritis via Inhibition of JAK2/STAT3 and NF-κB Pathways
– Biomedicine & Pharmacotherapy
Corrigendum: Nitazoxanide Reduces Bone Loss by Inhibition of RANKL-Induced Osteoclastogenesis
– Frontiers in Pharmacology